Literature DB >> 8529956

Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene.

K Hashimoto1, C Azuma, S Kamiura, T Kimura, T Nobunaga, T Kanai, M Sawada, S Noguchi, F Saji.   

Abstract

To investigate the clonality of uterine leiomyomas, we developed a PCR-based method involving the differential inactivation of the X-chromosome-linked phosphoglycerokinase (PGK) gene. Small DNA samples of 22 leiomyomas from 9 Japanese patients, showing heterozygosity at the BstXI site of the PGK gene, were digested with the methylation-sensitive restriction enzyme HpaII. Only the inactive (methylated) PGK gene allele was selectively amplified by PCR followed by digestion with BstXI and electrophoresis. All leiomyoma samples consisted of a single type of inactive allele, even though alleles were detected that were specific to each nodule. The results indicated that all leiomyoma nodules were unicellular in origin but independently generated in the uterus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8529956     DOI: 10.1159/000292336

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  23 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Estradiol-dependent uterine leiomyomas in transgenic mice.

Authors:  B Romagnolo; T Molina; G Leroy; C Blin; A Porteux; M Thomasset; A Vandewalle; A Kahn; C Perret
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 3.  Fibroids (uterine myomatosis, leiomyomas).

Authors:  Anne Lethaby; Beverley Vollenhoven
Journal:  BMJ Clin Evid       Date:  2015-06-02

4.  Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.

Authors:  Jennelle C Hodge; Tae-Min Kim; Jonathan M Dreyfuss; Priya Somasundaram; Nicole C Christacos; Marissa Rousselle; Bradley J Quade; Peter J Park; Elizabeth A Stewart; Cynthia C Morton
Journal:  Hum Mol Genet       Date:  2012-02-17       Impact factor: 6.150

Review 5.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

6.  Identification of proteins with different abundance associated with cell migration and proliferation in leiomyoma interstitial fluid by proteomics.

Authors:  Blendi Ura; Federica Scrimin; Cinzia Franchin; Giorgio Arrigoni; Danilo Licastro; Lorenzo Monasta; Giuseppe Ricci
Journal:  Oncol Lett       Date:  2017-03-29       Impact factor: 2.967

7.  Identifying the molecular signature of the interstitial deletion 7q subgroup of uterine leiomyomata using a paired analysis.

Authors:  Jennelle C Hodge; Peter J Park; Jonathan M Dreyfuss; Iman Assil-Kishawi; Priya Somasundaram; Luwam G Semere; Bradley J Quade; Allison M Lynch; Elizabeth A Stewart; Cynthia C Morton
Journal:  Genes Chromosomes Cancer       Date:  2009-10       Impact factor: 5.006

8.  Growth of uterine leiomyomata among premenopausal black and white women.

Authors:  Shyamal D Peddada; Shannon K Laughlin; Kelly Miner; Jean-Philippe Guyon; Karen Haneke; Heather L Vahdat; Richard C Semelka; Ania Kowalik; Diane Armao; Barbara Davis; Donna Day Baird
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-01       Impact factor: 11.205

Review 9.  Fibroids (uterine myomatosis, leiomyomas).

Authors:  Anne Elizabeth Lethaby; Beverley Janine Vollenhoven
Journal:  BMJ Clin Evid       Date:  2007-05-01

10.  Evaluation of cardiovascular risk factors in women with uterine leimyoma: is there a link with atherosclerosis?

Authors:  Nasir Sivri; Tülin Yalta; Cenk Sayın; Kenan Yalta; Fulya Ozpuyan; Ebru Taştekin; Ertan Yetkin
Journal:  Balkan Med J       Date:  2012-09-01       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.